XMU-MP-1 is able to efficiently inhibit MST1/2 activities in various cell types including hepatocytes, the macrophage cell line, osteosarcoma cell line [18], rat primary cardiomyocytes [19], microglial cells [20], and breast cancer cell lines [21]. Here, MST1 is linked to breast cancer.